Literature DB >> 8452684

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization.

S Murase1, J M Mathé, J Grenhoff, T H Svensson.   

Abstract

The effects of the non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist dizocilpine ((+)-MK-801) on the firing pattern of midbrain dopamine neurons were studied with single cell recording techniques in male albino rats anaesthetized with chloral hydrate. The extracellularly recorded electrical activity of single, identified dopamine neurons was studied with respect to firing rate, burst firing and regularity of firing. MK-801 (0.01-1.0 mg/kg IV) induced different effects in different subgroups of midbrain dopamine neurons. In the substantia nigra, firing rate was increased while the pattern was regularized and burst firing slightly increased. In the ventral tegmental area, firing rate and regularity of firing was also increased while effects on burst firing were bidirectional. Histological inspections revealed that neurons which responded with an increase in burst firing were mainly located in the nucleus paranigralis subdivision of the ventral tegmental area, while cells responding with a decrease were predominantly found in the nucleus parabrachialis pigmentosus subdivision. The effects of MK-801 were similar to previously described effects of phencyclidine, another non-competitive NMDA antagonist. The present effects of MK-801 might shed some light on the mechanisms involved in psychotic symptoms induced by phencyclidine and other non-competitive NMDA antagonists.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8452684     DOI: 10.1007/bf01244915

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  46 in total

1.  Phencyclidine activates rat A10 dopamine neurons but reduces burst activity and causes regularization of firing.

Authors:  L Pawlowski; J M Mathé; T H Svensson
Journal:  Acta Physiol Scand       Date:  1990-07

2.  [Participation of NMDA receptors in spontaneous burst firing of dopaminergic mesencephalic neurons].

Authors:  K Chergui; P J Charléty; H Akaoka; J L Brunet; C F Saunier; M Buda; T H Svensson; G Chouvet
Journal:  C R Acad Sci III       Date:  1991

3.  Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabeling density and neuronal associations.

Authors:  V E Bayer; V M Pickel
Journal:  J Neurosci       Date:  1990-09       Impact factor: 6.167

4.  NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

Authors:  A Imperato; M G Scrocco; S Bacchi; L Angelucci
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

5.  Ultrastructural localization of neurotensin-like immunoreactivity within dense core vesicles in perikarya, but not terminals, colocalizing tyrosine hydroxylase in the rat ventral tegmental area.

Authors:  V E Bayer; A C Towle; V M Pickel
Journal:  J Comp Neurol       Date:  1991-09-08       Impact factor: 3.215

6.  Organization of catecholamine neurons projecting to the frontal cortex in the rat.

Authors:  O Lindvall; A Björklund; I Divac
Journal:  Brain Res       Date:  1978-02-17       Impact factor: 3.252

7.  The cytoarchitecture of the interfascicular nucleus and ventral tegmental area of Tsai in the rat.

Authors:  O T Phillipson
Journal:  J Comp Neurol       Date:  1979-09-01       Impact factor: 3.215

8.  The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.

Authors:  M D Tricklebank; L Singh; R J Oles; C Preston; S D Iversen
Journal:  Eur J Pharmacol       Date:  1989-08-11       Impact factor: 4.432

9.  A comparison between the non-competitive NMDA antagonist dizocilpine (MK-801) and the competitive NMDA antagonist D-CPPene with regard to dopamine turnover and locomotor-stimulatory properties in mice.

Authors:  A Svensson; E Pileblad; M Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1991

Review 10.  Dopamine-containing neurons in the mammalian central nervous system: electrophysiology and pharmacology.

Authors:  L A Chiodo
Journal:  Neurosci Biobehav Rev       Date:  1988       Impact factor: 8.989

View more
  11 in total

Review 1.  Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

Authors:  K Fuxe; M Canals; M Torvinen; D Marcellino; A Terasmaa; S Genedani; G Leo; D Guidolin; Z Diaz-Cabiale; A Rivera; L Lundstrom; U Langel; J Narvaez; S Tanganelli; C Lluis; S Ferré; A Woods; R Franco; L F Agnati
Journal:  J Neural Transm (Vienna)       Date:  2006-10-27       Impact factor: 3.575

2.  Dopamine-mediated MK-801-induced elevation in food-based extinction responding in rats and associated changes in region-specific phosphorylated ERK.

Authors:  Matthew R Holahan; Melanie J Clarke; Delaney D Hines
Journal:  Psychopharmacology (Berl)       Date:  2010-07-23       Impact factor: 4.530

3.  Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia.

Authors:  Maximilian Tufvesson-Alm; Lilly Schwieler; Robert Schwarcz; Michel Goiny; Sophie Erhardt; Göran Engberg
Journal:  Neuropharmacology       Date:  2018-06-05       Impact factor: 5.250

4.  The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex.

Authors:  Anna Castañé; Francesc Artigas; Analía Bortolozzi
Journal:  Psychopharmacology (Berl)       Date:  2008-07-02       Impact factor: 4.530

Review 5.  Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.

Authors:  L Leriche; J Diaz; P Sokoloff
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

6.  Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.

Authors:  J L Andersson; G G Nomikos; M Marcus; P Hertel; J M Mathé; T H Svensson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-10       Impact factor: 3.000

7.  MK-801 inhibits L-DOPA-induced abnormal involuntary movements only at doses that worsen parkinsonism.

Authors:  Melanie A Paquette; Akari M Anderson; Jason R Lewis; Charles K Meshul; Steven W Johnson; S Paul Berger
Journal:  Neuropharmacology       Date:  2010-01-14       Impact factor: 5.250

8.  Intra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophrenia.

Authors:  Matthew R Holahan; Dan Madularu; Erin M McConnell; Ryan Walsh; Maria C DeRosa
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

Review 9.  Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options.

Authors:  Pierre Chue; Justine K Lalonde
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-08       Impact factor: 2.570

10.  Bidirectional variation in glutamate efflux in the medial prefrontal cortex induced by selective positive and negative allosteric mGluR5 modulators.

Authors:  Sarah N Isherwood; Trevor W Robbins; Jeffrey W Dalley; Anton Pekcec
Journal:  J Neurochem       Date:  2018-02-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.